Evidence map›Paper›PMID 28232800›Full record

ArticleFrontiers in pharmacology2017

Circulating ECV-Associated miRNAs as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis.

Joeri Lambrecht, Pieter Jan Poortmans, Stefaan Verhulst, Hendrik Reynaert, Inge Mannaerts, Leo A van Grunsven

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Biomarkers in Detection of Hepatitis C Virus Infection.Pathogens (Basel, Switzerland) · 2024
    Review
  6. Review
  7. Article
  8. Molecular Diagnosis and Cancer Prognosis-A Concise Review.Diagnostics (Basel, Switzerland) · 2023
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Best Practices and Progress in Precision-Cut Liver Slice Cultures.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Review
  18. Review
  19. Serum Exosomal miRNAs for Grading Hepatic Fibrosis Due to Schistosomiasis.International journal of molecular sciences · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joeri LambrechtLiver Cell Biology Lab, Department of Basic Biomedical Sciences, Vrije Universiteit Brussel Brussels, Belgium.
Pieter Jan PoortmansLiver Cell Biology Lab, Department of Basic Biomedical Sciences, Vrije Universiteit Brussel Brussels, Belgium.
Stefaan VerhulstLiver Cell Biology Lab, Department of Basic Biomedical Sciences, Vrije Universiteit Brussel Brussels, Belgium.
Hendrik ReynaertLiver Cell Biology Lab, Department of Basic Biomedical Sciences, Vrije Universiteit BrusselBrussels, Belgium; Department of Gastroenterology and Hepatology, Universitair Ziekenhuis BrusselBrussels, Belgium.
Inge MannaertsLiver Cell Biology Lab, Department of Basic Biomedical Sciences, Vrije Universiteit Brussel Brussels, Belgium.
Leo A van GrunsvenLiver Cell Biology Lab, Department of Basic Biomedical Sciences, Vrije Universiteit Brussel Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic liver diseaseextracellular vesicleshepatic stellate cellnon-coding RNAplasma

Identifiers

PMID28232800
PMCPMC5298975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.